Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports

ReutersSep 12, 2025 9:48 AM

Sept 12 (Reuters) - Kenvue's KVUE.N interim Chief Executive Officer Kirk Perry met Robert F. Kennedy Jr. to try and dissuade the U.S. health secretary from including Tylenol as a potential cause of autism in an upcoming report, the Wall Street Journal reported on Friday, citing a person familiar with the matter.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Intel Just Hit $94.75 While the Nasdaq Fell — and Institutions Are Still Buying. Is INTC a Buy?

Intel Corporation (NASDAQ: INTC) closed the day at $94.75, notching a second consecutive +12.10% day, and is now up a total +40.43% over the past five days. The key difference between Wednesday's action and the post-earnings party over the past week is this: Intel's volume on Wednesday was 227.3 mil

Is Lululemon Stock a Buy or a Risky Bet Amidst Financial Pressure and Management Changes?

TradingKey - An athleisure company, Lululemon Athletica（LULU）, has built a very successful niche in the fashionable athletic wear category.

Featured Tools

Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports

Recommended Articles

Intel Just Hit $94.75 While the Nasdaq Fell — and Institutions Are Still Buying. Is INTC a Buy?

Can Robinhood Stock Surge Again in 2026?

Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

VOO Stock Price: Is the S&P 500 ETF Still the Smarter Buy vs QQQ?

Is Lululemon Stock a Buy or a Risky Bet Amidst Financial Pressure and Management Changes?